当前对局部软组织瘤的系统治疗的立场:临床医生的观点
Archana Sasi1, Sameer Rastogi1
1Department of Medical Oncology, Dr. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110029, India.
Future oncology (London, England)
|October 20, 2023
概括
针对局部软组织肉瘤 (STS) 的全身疗法正在讨论中. 本综述总结了针对可切除性STS的化疗,向治疗和免疫治疗的证据,以指导高风险患者的临床决策.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 医学瘤学 医学瘤学
背景情况:
- 软组织肉瘤 (STS) 是一种罕见的,异质的瘤,起源于介质细胞组织.
- 手术是主要治疗方法,但高复发率需要辅助或新辅助系统治疗高风险病例.
- 尽管进行了广泛的研究,但化疗在局部性STS中的有效性仍然存在争议.
研究的目的:
- 审查当前关于本地化,可切除的软组织瘤的全身治疗的证据.
- 帮助临床医生做出关于辅助性和/或新辅助性化疗,向性治疗和免疫治疗的决策.
- 识别高风险的STS患者,他们可能从全身治疗策略中获益最多.
主要方法:
- 在过去三十年中发表的临床试验和元分析的系统审查.
- 对化学疗法,向药物和局部性STS免疫治疗策略的证据分析.
- 专注于涉及干部和四肢可切除软组织肉瘤的研究.
主要成果:
- 关于化疗在局部性STS中的作用的证据仍然存在争议.
- 对有针对性和免疫治疗策略有新的兴趣,以改善结果.
- 准确识别高风险患者对于优化全身治疗效益至关重要.
结论:
- 针对局部性,可切除性STS的全身治疗决策需要仔细考虑个体患者的风险因素.
- 需要进一步的研究来澄清化疗的作用,并探索新的向和免疫治疗方法的潜力.
- 本综述总结了当前的证据,以支持在管理局部性STS的临床决策.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538


